Azithromax Tablets 250 mg (Azithromycin Hydrate)

Adult dose

○ Adults 1) Sexually transmitted infections caused by Chlamydia trachomatis: Administer a single dose of 1g (potency) of azithromycin. 2) Other indications - 3-day regimen: Administer 500mg (potency) of azithromycin once daily for 3 days [total dose 1.5g (potency)]. - 5-day regimen: Administer a single dose of 500mg (potency) on the first day. Starting on the second day, administer 250mg (potency) once daily for 4 days [total dose 1.5g (potency)]. ○ Older adults Administer the same dosage as for adults.

Child dose

○ Children (45Kg or more) Administer the same dosage as for adults.

This medication is a macrolide antibiotic, and serious allergic reactions can rarely occur during use, so caution is advised. In particular, if symptoms such as angioedema, anaphylaxis, or severe skin rash occur, treatment should be stopped immediately and medical attention should be sought. Additionally, this medication can rarely cause serious diarrhea or colitis due to Clostridium difficile by altering the intestinal microbiota, so prompt diagnosis and treatment are needed if diarrhea symptoms occur. Patients with hypersensitivity or allergy to macrolide antibiotics should not use this medication, and patients taking ergot alkaloids should also avoid this medication. In patients with significantly impaired kidney function or severe liver disease, the exposure to this medication may increase or pose a risk of liver damage, so it should be administered cautiously. This medication generally has good tolerance, but side effects such as nausea, vomiting, diarrhea, liver function abnormalities, and rash may occur rarely, and consultation with medical personnel is needed if symptoms arise. Particularly, symptoms such as hearing loss, tinnitus, dizziness, and cardiac arrhythmias may occur, so these symptoms should also be monitored carefully. While taking this medication, there is a risk of reinfection, so observation of infection symptoms is necessary. This medication can affect the electrical activity of the heart, thus patients with congenital QT prolongation, heart disease, or electrolyte abnormalities should be especially cautious. Patients with myasthenia gravis may experience worsening symptoms while taking this medication, so consultation with medical personnel is essential. This medication may alter blood concentration when taken with food in some formulations, so it is important to carefully follow dosage instructions. The use of this medication during pregnancy should be limited to cases where its safety for the fetus has not been fully established, and if breastfeeding, careful consideration should be given as some of the drug may be transmitted through breast milk. Elderly individuals may have a higher risk of arrhythmias and should take it as directed by medical personnel. There may be interactions with other medications, so those currently taking other medications should inform medical personnel, particularly with some anticoagulants, immunosuppressants, and cardiac medications caution is needed. In case of overdose, general symptomatic treatment should be administered, and the medication should be kept out of reach of children and stored in its original container to prevent misuse or quality degradation.

Angioedema, anaphylaxis, acute generalized exanthematous pustulosis, Stevens-Johnson syndrome, toxic epidermal necrolysis, drug reaction with eosinophilia and systemic symptoms, mild neutropenia, hearing loss, deafness, tinnitus, nausea, vomiting, diarrhea, loose stools, abdominal discomfort, abdominal bloating, hepatic dysfunction, rash, vascular edema, moniliasis, vaginitis, thrombocytopenia, leukopenia, granulocytopenia, shock, dyspnea, anorexia, aggressive reactions, nervous hyperreactivity, agitation, anxiety, dizziness, convulsions, headache, hyperactivity, sensory disturbance, drowsiness, sensory loss, syncope, taste/smell disturbances and loss, palpitations, ventricular tachycardia, arrhythmias, QT prolongation, Torsades de pointes, hypotension, dyspepsia, constipation, pseudomembranous enterocolitis, pancreatitis, pyloric stenosis, tongue discoloration, hepatitis, jaundice, cholestatic jaundice, hepatic necrosis, hepatic failure, itching, phototoxic reactions, edema, urticaria, erythema multiforme, arthralgia, rhabdomyolysis, myalgia, malaise, CK elevation, increased myoglobin in blood and urine, interstitial nephritis, acute renal failure, muscle weakness, fatigue, lethargy, fever, cough, dyspnea, abnormal chest X-ray, interstitial pneumonia, eosinophilic pneumonia, infantile hypertrophic pyloric stenosis

This medication should be stored in a tightly closed container to protect it from air and moisture, preferably in a cool place below 25 degrees Celsius. Doing so can help maintain the effectiveness of the medication for a longer time.

Appearance

White oval film-coated tablet

Package unit

30 tablets (10 tablets/PTPX3)